Activation or upregulation of the CaCC TMEM16A, an upstream target on the cell surface, can initiate a variety downstream signaling pathways affecting various pathophysiological processes [e.g., as shown for Ras-Raf-MEK-ERK in cancer (Duvvuri et al., 2012)]. The gene discussed is MAP2K7; the disease is cancer.